The #AIEye Episode 365: NICE (NASDAQ: $NICE) Launches Trial Edition of RPA Studio and Virtusa (NasdaqGS: $VRTU) Announces vLife Marketplace with #AI Solutions for Healthcare and Life Sciences Organizations
Global NLP Market to Reach $80.68 Billion by 2026
Point Roberts WA, Vancouver BC – June 9, 2020 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today’s podcast:
Read this in full at https://www.investorideas.com/news/2020/artificial-intelligence/06091AIEye-NICE-VRTU-vLife.asp
Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (NasdaqGS:NICE) (NasdaqGS:VRTU)
NICE Ltd. (NasdaqGS:NICE) has launched a trial version for its next-generation Automation Studio, NICE Robotic Automation Community Edition. This version will be free of charge for six months, and “helps boost development skills in both attended and unattended automations.” Barry Cooper, NICE Enterprise Group President, commented:
"We are excited to see more and more developers turn to automation as their next career move. This is apparent in our growing RPA developer community, as well as the many new automation-related roles we see springing in the market. By bringing this free automation trial version, we are striving to make automation more accessible to today’s work-from-home developers, who play a role in creating solutions for supporting their business and service operations."
Virtusa Corporation (NasdaqGS:VRTU) has announced the new vLife marketplace providing “Healthcare and Life Sciences organizations with click, try, and buy access to applications and solutions that will increase efficiency and lower costs, including for virtual care,” even as these organizations face work restrictions imposed by COVID-19 measures. According to the press release, the marketplace “incorporates more than 500 AI-based technologies from Virtusa and partners,” including “computer vision, synthetic data generation tools, platform AI, and faster AI algorithms to gain high-level understanding from data, digital images, and videos.” Anthony Lange, SVP, healthcare and life sciences, Virtusa, said:
“COVID-19 has disrupted the Global Healthcare ecosystem. We prioritized our resources to launch vLife 4.0 to mitigate this disruption and enable our clients to engage with patients, members, and providers safely at scale while controlling costs."
Global NLP Market to Reach $80.68 Billion by 2026
A report from Markets and Markets finds that the global AI in Healthcare market will grow from $4.9 billion in 2020 to $45.2 billion by 2026 with a compound annual growth rate (CAGR) of 44.9 percent in the forecast period. An excerpt from the report description outlines key drivers in the market:
The major factors driving the market growth are the increasing volume of healthcare data and growing complexities of datasets driving the need for AI, the intensifying need to reduce towering healthcare costs, improving computing power and declining hardware costs, growing number of cross-industry partnerships and collaborations, and rising imbalance between health workforce and patients driving the need for improvised healthcare services. Another major factor fueling the market growth currently is the adoption of this technology by multiple pharmaceutical and biotechnology companies across the world to expedite vaccine or drug development processes for COVID-19.
Sam Mowers, Investorideas.com
For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Contact Investorideas.com
800 665 0411